N1-substituted 3,4-dihydropyrimidine-2-ketone-C60 compound and preparation method thereof
A technology of dihydropyrimidine and compounds, which is applied in the field of drug synthesis, can solve problems such as inability to insert into biomembranes, and achieve the effects of stable target products, fewer by-products, and high yields
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0034] a. Weigh 1-(4-bromobutyl)-4-phenyl-5-ethoxycarbonyl-6-methyl-3,4-dihydropyrimidin-2-one (0.60g, 1.50mmol) in a circle In the bottom flask, add 30mL of acetone to make it completely dissolved, then add p-hydroxybenzaldehyde (1.11g, 9.00mmol) and 3.00g of anhydrous potassium carbonate, stir at room temperature for 24 hours, TLC traces the reaction is complete;
[0035] b. After the reaction is complete, the acetone in the solution is evaporated under reduced pressure, then distilled water and dichloromethane are added for extraction, the organic phase is collected, filtered, dried, and column chromatography is carried out with 200-300 mesh silica gel, and the eluent is acetic acid Ethyl ester: Petroleum ether (1:3, v / v), after precipitation and drying, white solid 1-[1-(4-formyl)phenyl]butoxy-4-phenyl-5-ethoxy Carbonyl-6-methyl-3,4-dihydropyrimidin-2-one;
[0036] c. Weigh C 60 (100mg, 0.14mmol) was added to a three-necked flask with toluene (130mL), stirred at room tem...
Embodiment 2
[0041] Repeat Example 1 with the following differences: the raw material is changed to 1-(4-bromobutyl)-4-p-methylphenyl-5-ethoxycarbonyl-6-methyl-3,4-dihydropyrimidine- 2-keto (0.60g, 1.50mmol), C 60 (150mg, 0.21mmol), the eluent was changed to ethyl acetate: petroleum ether (1:4, v / v), toluene: ethyl acetate (7:1, v / v), and 40mg of tan solid was obtained. The rate is 24.1%.
[0042] The spectral data of the product are as follows: 1 H NMR (500MHz, CDCl 3 )δ7.71(br s,2H,β-phenyl),7.13(d,J=7.5Hz,2H,DHPM-phenyl),7.08(d,J=7.5Hz,2H,DHPM-phenyl),6.93(d ,J=6.5Hz,2H,α-phenyl),5.39(br s,1H,NH,exchanged with D 2 O),5.33(br s,1H,CH),4.98(d,J=9.0Hz,1H,β-pyrrole CH 2 ),4.88(s,1H,β-pyrrole CH),4.24(d,J=9.0Hz,1H,β-pyrrole CH 2 ),4.08-4.13(m,2H,ester-CH 2 ),3.89-4.01(m,3H,NCH 2 ,OCH 2 ),3.61-3.72(m,1H,NCH 2 ),2.79(s,3H,6-CH 3 ),2.52(s,3H,N-CH 3 ),2.27(s,3H,phenyl-CH 3 ),1.67-1.85(m,4H,2×CH 2 ),1.18(t,J=6.9Hz,3H,ester-CH 3 ). 13 C NMR (126MHz, CDCl 3 )δ166.07,158.98,154.10,1...
Embodiment 3
[0045] Repeat Example 1 with the following differences: the raw material is changed to 1-(4-bromobutyl)-4-p-methoxyphenyl-5-ethoxycarbonyl-6-methyl-3,4-dihydropyrimidine -2-ketone (0.64g, 1.50mmol), C 60 (150mg, 0.21mmol), the reflux time was changed to 6 hours, the eluent was changed to ethyl acetate: petroleum ether (1:1.5, v / v), toluene: ethyl acetate (4:1, v / v), 50 mg of tan solid was obtained with a yield of 29.7%.
[0046] The spectral data of the product are as follows: 1 H NMR (500MHz, CDCl 3 )δ7.70(br s,2H,β-phenyl),7.16(d,J=8.5Hz,2H,DHPM-phenyl),6.94(d,J=7.0Hz,2H,DHPM-phenyl),6.81(d ,J=8.5Hz,2H,α-phenyl),5.36(br s,1H,NH,exchanged with D 2 O),5.31(br s,1H,CH),4.98(d,J=9.5Hz,1H,β-pyrrole CH 2 ),4.88(s,1H,β-pyrrole CH),4.24(d,J=9.0Hz,1H,β-pyrrole CH 2 ),4.08(q,J=7.0Hz,2H,ester-CH 2 ),3.94-3.97(m,3H,NCH 2 ,OCH 2 ),3.74(s,3H,phenyl-OCH 3 ),3.66-3.71(m,1H,NCH 2 ),2.79(s,3H,6-CH 3 ),2.52(s,3H,N-CH 3 ),1.68-1.82(m,4H,2×CH 2 ),1.17(t,J=7.0Hz,3H,ester-CH 3 ). 1...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 